POST Online Media Lite Edition



 

Lorus appoints Brad Thompson to the board of directors

Staff writer |
Toronto, ON, Canada – Lorus Therapeutics Inc., a biopharmaceutical company, announced that Brad Thompson has been appointed to the board of directors of Lorus. [break]


Dr. Thompson is an experienced and respected biotechnology professional who has held the positions of Chairman of the Board and President and Chief Executive Officer of Oncolytics Biotech Inc. since April 1999. Prior to his role with Oncolytics Dr. Thompson was the Chief Executive Officer of Synsorb Biotech from 1994 to 1999. Dr. Thompson is also currently a board member of Immuno - June 28, 2013, Toronto, ON, Canada – Lorus Therapeutics Inc., a biopharmaceutical company, announced that Brad Thompson has been appointed to the board of directors of Lorus.

Article continues below






Dr. Thompson is an experienced and respected biotechnology professional who has held the positions of Chairman of the Board and President and Chief Executive Officer of Oncolytics Biotech Inc. since April 1999. Prior to his role with Oncolytics Dr. Thompson was the Chief Executive Officer of Synsorb Biotech from 1994 to 1999. Dr. Thompson is also currently a board member of Immunovaccine Inc.

 LATEST MOVES FROM Toronto, ON, Canada – Lorus Therapeutics Inc., a biopharmaceutical company, announced that Brad Thompson has been appointed to the board of directors of Lorus. [break]


Dr. Thompson is an experienced and respected biotechnology professional who has held the positions of Chairman of the Board and President and Chief E 


What to read next

Corby Spirit and Wine appoints new director
Chesapeake Energy names R. Brad Martin as new chairman
Virtual Instruments adds John W. Thompson to board of directors